Research Questions:
1. What is the relationship between frailty status and the development of advanced CKM syndrome in the UK Biobank cohorts?
2. What is the relationship between changes in frailty status and the development of advanced CKM syndrome in the UK Biobank cohorts?
3. What are the mediating factors through which frailty status affects advanced CKM syndrome?
Objectives:
1. To determine the association between frailty status and the incidence of advanced CKM syndrome in the UK Biobank cohorts.
2. To explore the mediating factors through which frailty status affects advanced CKM syndrome.
3. To evaluate the impact of frailty status modification on the incidence of CKM syndrome.
Scientific Rationale:
Frailty is a state of increased vulnerability to the stressor because of decreased reserves across multiple physiological systems. It is associated with adverse health outcomes, including cardiovascular diseases, chronic kidney disease, and metabolic disorders. The CKM syndrome represents a complex interplay between these conditions, which often coexist and exacerbate each other. Understanding the relationship between frailty and CKM syndrome is crucial for developing targeted interventions to improve health outcomes in at-risk populations.
The UK Biobank provides a rich dataset with comprehensive health information, including detailed assessments of frailty and long-term follow-up data on cardiovascular, kidney, and metabolic outcomes. This project aims to leverage this resource to elucidate the mechanisms linking frailty to CKM syndrome and to identify potential biomarkers that could inform early intervention strategies.